Disclaimers May Be "Subterfuge" For Disease Claims, PhRMA Exec Warns
This article was originally published in The Tan Sheet
Executive Summary
FDA should be cautious in allowing a disclaimer statement that could mislead consumers into believing dietary supplements can cure or prevent disease, a PhRMA rep maintained at FDA's Aug. 4 public meeting on the regulation of supplement structure/ function claims in Washington, D.C.